Exact Mass: 258.0786

Exact Mass Matches: 258.0786

Found 121 metabolites which its exact mass value is equals to given mass value 258.0786, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ribothymidine

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H14N2O6 (258.0852)


Ribothymidine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 3506820, 17044778, 17264127, 16799933) [HMDB] Ribothymidine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID:3506820, 17044778, 17264127, 16799933). 5-Methyluridine is a is an endogenous methylated nucleoside found in human fluids. 5-Methyluridine is a is an endogenous methylated nucleoside found in human fluids.

   

Imidazoleacetic acid riboside

2-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-imidazol-4-yl}acetic acid

C10H14N2O6 (258.0852)


Imidazoleacetic acid riboside is a metabolite of imidazoleacetic acid (itself histamines oxidative metabolite). (PMID: 7616240). In kidney glomeruli, histamine is predominantly catabolized to acid metabolites of the diamine oxidase (histaminase) pathway, imidazoleacetic acid and Imidazoleacetic acid riboside. (PMID: 7616240). Imidazoleacetic acid riboside is a metabolite of imidazoleacetic acid (itself histamines oxidative metabolite). (PMID: 7616240)

   

(2S)-2-Amino-5-[[(1S,2R)-1-carboxy-2-hydroxybut-3-ynyl]amino]-5-oxopentanoic acid

(2S)-2-Amino-5-[[(1S,2R)-1-carboxy-2-hydroxybut-3-ynyl]amino]-5-oxopentanoic acid

C10H14N2O6 (258.0852)


   

3-Methyluridine

1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H14N2O6 (258.0852)


3-Methyluridine is a modified nucleoside of cellular RNA. All modifications are formed post-transcriptionally in RNA from the normal nucleosides by modifying enzymes, especially specific RNA-methyltransferases and RNA-synthetases. Due to the lack of specific phosphorylases for modified nucleosides they cannot be recycled for synthesizing RNA, so they are excreted quantitatively in urine. (PMID 15906010) [HMDB] 3-Methyluridine is a modified nucleoside of cellular RNA. All modifications are formed post-transcriptionally in RNA from the normal nucleosides by modifying enzymes, especially specific RNA-methyltransferases and RNA-synthetases. Due to the lack of specific phosphorylases for modified nucleosides they cannot be recycled for synthesizing RNA, so they are excreted quantitatively in urine. (PMID 15906010). 3-Methyluridine (N3-Methyluridine) is a modified RNA nucleoside. 3-Methyluridine is often presents as?RNA modification which can be detected in 23S?rRNA?of?archaea, 16S and 23S rRNA of?eubacteria, and 18S, 25S, and 28S of eukaryotic ribosomal RNAs[1][2]. 3-Methyluridine (N3-Methyluridine) is a modified RNA nucleoside. 3-Methyluridine is often presents as?RNA modification which can be detected in 23S?rRNA?of?archaea, 16S and 23S rRNA of?eubacteria, and 18S, 25S, and 28S of eukaryotic ribosomal RNAs[1][2].

   

Cysteinyl-Histidine

2-[(2-Amino-1-hydroxy-3-sulphanylpropylidene)amino]-3-(1H-imidazol-5-yl)propanoic acid

C9H14N4O3S (258.0787)


Cysteinyl-Histidine is a dipeptide composed of cysteine and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Histidylcysteine

(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C9H14N4O3S (258.0787)


Histidylcysteine is a dipeptide composed of histidine and cysteine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

2'-O-Methyluridine

1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H14N2O6 (258.0852)


2-O-Methyluridine belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. 2-O-Methyluridine was identified as one of forty plasma metabolites that could be used to predict gut microbiome Shannon diversity (PMID: 31477923). Shannon diversity is a metric that summarizes both species abundance and evenness, and it has been suggested as a marker for microbiome health.

   

5-Hydroxymethyl-2'-deoxyuridine

4-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)-1,2-dihydropyrimidin-2-one

C10H14N2O6 (258.0852)


   

arabinofuranosylthymine

1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H14N2O6 (258.0852)


   

benzyl styryl sulfone

[(2-phenylethenesulfonyl)methyl]benzene

C15H14O2S (258.0714)


   

Histidinyl-Cysteine

2-{[2-amino-1-hydroxy-3-(1H-imidazol-5-yl)propylidene]amino}-3-sulphanylpropanoic acid

C9H14N4O3S (258.0787)


   

U 50228

1-Methylpseudouridine

C10H14N2O6 (258.0852)


N1-methyl-pseudouridine (1-Methylpseudouridine), a methylpseudouridine, outperforms 5 mC and 5 mC/N1-methyl-pseudouridine in translation. N1-methyl-pseudouridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density[1].

   
   

1-methyl-3-(4-phenoxyphenyl)thiourea

1-methyl-3-(4-phenoxyphenyl)thiourea

C14H14N2OS (258.0827)


   

N1-Methylpseudouridine

N1-Methylpseudouridine

C10H14N2O6 (258.0852)


   

2-O-Methyl Uridine

2-O-Methyl Uridine

C10H14N2O6 (258.0852)


   

SCHEMBL16359928

SCHEMBL16359928

C10H14N2O6 (258.0852)


   

chinensisol

chinensisol

C11H14O7 (258.0739)


   
   

scleropentaside A

scleropentaside A

C11H14O7 (258.0739)


   
   

lamiolactone

lamiolactone

C11H14O7 (258.0739)


   

Lamiophlomiol C

Lamiophlomiol C

C11H14O7 (258.0739)


   
   
   

3-Methyluridine

N3-Methyluridine

C10H14N2O6 (258.0852)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.102 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.109 3-Methyluridine (N3-Methyluridine) is a modified RNA nucleoside. 3-Methyluridine is often presents as?RNA modification which can be detected in 23S?rRNA?of?archaea, 16S and 23S rRNA of?eubacteria, and 18S, 25S, and 28S of eukaryotic ribosomal RNAs[1][2]. 3-Methyluridine (N3-Methyluridine) is a modified RNA nucleoside. 3-Methyluridine is often presents as?RNA modification which can be detected in 23S?rRNA?of?archaea, 16S and 23S rRNA of?eubacteria, and 18S, 25S, and 28S of eukaryotic ribosomal RNAs[1][2].

   

Spongothymidine

Thymine-beta-D-arabinofuranoside

C10H14N2O6 (258.0852)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents

   

Ribothymidine

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H14N2O6 (258.0852)


A methyluridine having a single methyl substituent at the 5-position on the uracil ring. 5-Methyluridine is a is an endogenous methylated nucleoside found in human fluids. 5-Methyluridine is a is an endogenous methylated nucleoside found in human fluids.

   

1-Methylpseudouridine

1-Methylpseudouridine

C10H14N2O6 (258.0852)


N1-methyl-pseudouridine (1-Methylpseudouridine), a methylpseudouridine, outperforms 5 mC and 5 mC/N1-methyl-pseudouridine in translation. N1-methyl-pseudouridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density[1].

   

2-O-Methyluridine

2-O-Methyluridine

C10H14N2O6 (258.0852)


   

3-O-Methyluridine

4-[1-[(2-methylphenyl)methyl]benzimidazol-2-yl]-1,2,5-oxadiazol-3-amine

C10H14N2O6 (258.0852)


   

5-Methyluridine

5-Methyluridine

C10H14N2O6 (258.0852)


CONFIDENCE standard compound; INTERNAL_ID 320 5-Methyluridine is a is an endogenous methylated nucleoside found in human fluids. 5-Methyluridine is a is an endogenous methylated nucleoside found in human fluids.

   

5-Hydroxymethyl-deoxyuridine

5-Hydroxymethyl-deoxyuridine

C10H14N2O6 (258.0852)


   

5-Methyl-uridine

5-Methyl-uridine

C10H14N2O6 (258.0852)


   
   
   

Cys-His

2-[2-amino-3-(1H-imidazol-5-yl)propanamido]-3-sulfanylpropanoic acid

C9H14N4O3S (258.0787)


   

His-cys

2-(2-amino-3-sulfanylpropanamido)-3-(1H-imidazol-5-yl)propanoic acid

C9H14N4O3S (258.0787)


   

6-(2,2-DIMETHYL-PROPIONYLAMINO)-PYRIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE

6-(2,2-DIMETHYL-PROPIONYLAMINO)-PYRIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE

C11H15ClN2O3 (258.0771)


   

(4-chlorophenyl)-(4-propylphenyl)methanone

(4-chlorophenyl)-(4-propylphenyl)methanone

C16H15ClO (258.0811)


   

Cyclo(-glu-glu)

3-[(2S,5S)-5-(2-carboxyethyl)-3,6-dioxopiperazin-2-yl]propanoic acid

C10H14N2O6 (258.0852)


   

1-(4-Benzyloxyphenyl)-2-thiourea

1-(4-Benzyloxyphenyl)-2-thiourea

C14H14N2OS (258.0827)


   

1-[2-FLUORO-4-(METHYLSULFONYL)PHENYL]PIPERAZINE

1-[2-FLUORO-4-(METHYLSULFONYL)PHENYL]PIPERAZINE

C11H15FN2O2S (258.0838)


   

1-[4-FLUORO-2-(METHYLSULFONYL)PHENYL]PIPERAZINE

1-[4-FLUORO-2-(METHYLSULFONYL)PHENYL]PIPERAZINE

C11H15FN2O2S (258.0838)


   

3-CHLORO-4-ISO-PROPYLBENZOPHENONE

3-CHLORO-4-ISO-PROPYLBENZOPHENONE

C16H15ClO (258.0811)


   

(3-chlorophenyl)-(4-propylphenyl)methanone

(3-chlorophenyl)-(4-propylphenyl)methanone

C16H15ClO (258.0811)


   

2-[2-Oxo-2-(4-fluorophenyl)ethyl]benzoic acid

2-[2-Oxo-2-(4-fluorophenyl)ethyl]benzoic acid

C15H11FO3 (258.0692)


   

Benzeneacetic acid, a-(phenylthio)-, hydrazide

Benzeneacetic acid, a-(phenylthio)-, hydrazide

C14H14N2OS (258.0827)


   

4-[(2,4-dichlorophenyl)methyl]piperidin-4-amine

4-[(2,4-dichlorophenyl)methyl]piperidin-4-amine

C12H16Cl2N2 (258.069)


   

2-(4-(METHYLTHIO)-[1,1-BIPHENYL]-3-YL)ACETIC ACID

2-(4-(METHYLTHIO)-[1,1-BIPHENYL]-3-YL)ACETIC ACID

C15H14O2S (258.0714)


   

1-[(4-Fluorophenyl)sulfonyl]-4-methylpiperazine

1-[(4-Fluorophenyl)sulfonyl]-4-methylpiperazine

C11H15FN2O2S (258.0838)


   

4-CHLORO-4-ISO-PROPYLBENZOPHENONE

4-CHLORO-4-ISO-PROPYLBENZOPHENONE

C16H15ClO (258.0811)


   

2-CHLORO-1,2-DI-P-TOLYL-ETHANONE

2-CHLORO-1,2-DI-P-TOLYL-ETHANONE

C16H15ClO (258.0811)


   

2-C-Methyluridine

2-C-Methyluridine

C10H14N2O6 (258.0852)


2'-C-methyluridine is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1].

   

4-(4-chlorophenyl)-3-phenyl-butan-2-one

4-(4-chlorophenyl)-3-phenyl-butan-2-one

C16H15ClO (258.0811)


   

diethyl 2,4,6-trioxoheptanedioate

diethyl 2,4,6-trioxoheptanedioate

C11H14O7 (258.0739)


   

3-(Diphenylphosphino)propionic acid

3-(Diphenylphosphino)propionic acid

C15H15O2P (258.081)


   

2-Cyanophenylboronic acid MIDA ester

2-Cyanophenylboronic acid MIDA ester

C12H11BN2O4 (258.0812)


   

3-(6-Methyl-4,8-dioxo-1,3,6,2-dioxazaborocan-2-yl)benzonitrile

3-(6-Methyl-4,8-dioxo-1,3,6,2-dioxazaborocan-2-yl)benzonitrile

C12H11BN2O4 (258.0812)


   

2-((4-Methylbenzyl)thio)benzoic acid

2-((4-Methylbenzyl)thio)benzoic acid

C15H14O2S (258.0714)


   

4-[(N,N-DIMETHYLGLYCYL)AMINO]BENZOIC ACID HYDROCHLORIDE

4-[(N,N-DIMETHYLGLYCYL)AMINO]BENZOIC ACID HYDROCHLORIDE

C11H15ClN2O3 (258.0771)


   

3-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)-5-METHOXYPYRIDINE

3-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)-5-METHOXYPYRIDINE

C11H15ClN2O3 (258.0771)


   

3-Cyclopropylmethoxy-4-difluoromethoxybenzoic Acid

3-Cyclopropylmethoxy-4-difluoromethoxybenzoic Acid

C12H12F2O4 (258.0704)


   

4-(2-nitrophenoxy)piperidine,hydrochloride

4-(2-nitrophenoxy)piperidine,hydrochloride

C11H15ClN2O3 (258.0771)


   

4-(3-Nitrophenoxy)piperidine hydrochloride (1:1)

4-(3-Nitrophenoxy)piperidine hydrochloride (1:1)

C11H15ClN2O3 (258.0771)


   
   

4-(4-Nitrophenoxy)piperidine hydrochloride (1:1)

4-(4-Nitrophenoxy)piperidine hydrochloride (1:1)

C11H15ClN2O3 (258.0771)


   

tetraethyl pyrophosphite

tetraethyl pyrophosphite

C8H20O5P2 (258.0786)


   

METHYL 3-[(PHENYLTHIO)METHYL]BENZOATE

METHYL 3-[(PHENYLTHIO)METHYL]BENZOATE

C15H14O2S (258.0714)


   

1-(3,4-Dichlorobenzyl)-4-piperidinamine

1-(3,4-Dichlorobenzyl)-4-piperidinamine

C12H16Cl2N2 (258.069)


   

N-1-Naphthylethylenediamine dihydrochloride

N-(1-Naphthyl)ethylenediamine dihydrochloride

C12H16Cl2N2 (258.069)


   

Sulnidazole

Sulnidazole

C9H14N4O3S (258.0787)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

ISOQUINOLIN-1-YL-THIOMORPHOLIN-4-YL-METHANONE

ISOQUINOLIN-1-YL-THIOMORPHOLIN-4-YL-METHANONE

C14H14N2OS (258.0827)


   

2-[(Diphenylmethyl)thio]acetic Acid

2-[(Diphenylmethyl)thio]acetic Acid

C15H14O2S (258.0714)


   

ethyl 4-phenylsulfanylbenzoate

ethyl 4-phenylsulfanylbenzoate

C15H14O2S (258.0714)


   

2-(chloromethyl)oxirane,3-(2,3-dihydroxypropoxy)propane-1,2-diol

2-(chloromethyl)oxirane,3-(2,3-dihydroxypropoxy)propane-1,2-diol

C9H19ClO6 (258.087)


   

Di-tert-butyl Chloromethyl Phosphate

Di-tert-butyl Chloromethyl Phosphate

C9H20ClO4P (258.0788)


   

2-CHLORO-N-(2,2-DIMETHOXY-ETHYL)-N-METHYL-ISONICOTINAMIDE

2-CHLORO-N-(2,2-DIMETHOXY-ETHYL)-N-METHYL-ISONICOTINAMIDE

C11H15ClN2O3 (258.0771)


   

Dimethyl (3,3-difluoro-2-oxoheptyl)phosphonate

Dimethyl (3,3-difluoro-2-oxoheptyl)phosphonate

C9H17F2O4P (258.0832)


   

4,4-OXYBIS(1,4-BENZENE)DIBORONIC ACID

4,4-OXYBIS(1,4-BENZENE)DIBORONIC ACID

C12H12B2O5 (258.0871)


   

benzyl 3-fluoro-4-formylbenzoate

benzyl 3-fluoro-4-formylbenzoate

C15H11FO3 (258.0692)


   

METHYL 4-[(PHENYLTHIO)METHYL]BENZOATE

METHYL 4-[(PHENYLTHIO)METHYL]BENZOATE

C15H14O2S (258.0714)


   

2-(Trimethylsilyl)ethyl 3-Nitro-1H-1,2,4-triazole-1-carboxylate

2-(Trimethylsilyl)ethyl 3-Nitro-1H-1,2,4-triazole-1-carboxylate

C8H14N4O4Si (258.0784)


   

bis(trimethylsilyl) but-2-ynedioate

bis(trimethylsilyl) but-2-ynedioate

C10H18O4Si2 (258.0744)


   

5-Hydroxymethyl-2-deoxyuridine

5-Hydroxymethyl-2-deoxyuridine

C10H14N2O6 (258.0852)


D000970 - Antineoplastic Agents 5-Hydroxymethyl-2'-deoxyuridine is a nucleoside analog. 5-Hydroxymethyl-2'-deoxyuridine inhibits the replication of multiple human leukemia cell lines with IC50 values of 1.7-5.8 μM. 5-Hydroxymethyl-2'-deoxyuridine prolongs the survival of mice carrying L1210 leukemia. 5-Hydroxymethyl-2'-deoxyuridine can be used for the research of cell replication and leukemia[1][2][3].

   

2-(2-aminophenyl)sulfanyl-N-phenylacetamide

2-(2-aminophenyl)sulfanyl-N-phenylacetamide

C14H14N2OS (258.0827)


   

H-Asp(OBzl)-NH2.HCl

H-Asp(OBzl)-NH2.HCl

C11H15ClN2O3 (258.0771)


   

Benzoic acid, 4-(cyclopropylMethoxy)-3-(difluoroMethoxy)-

Benzoic acid, 4-(cyclopropylMethoxy)-3-(difluoroMethoxy)-

C12H12F2O4 (258.0704)


   

3-(2-AMINOPHENYL)-N-METHYLPROPANAMIDE

3-(2-AMINOPHENYL)-N-METHYLPROPANAMIDE

C11H13F3N2Si (258.08)


   

Flutafuranol (18F)

Flutafuranol (18F)

C14H11FN2O2 (258.0805)


C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate

   

1-beta-D-Arabinofuranosylthymine

1-beta-D-Arabinofuranosylthymine

C10H14N2O6 (258.0852)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents

   

3-Methylpseudouridine

3-Methylpseudouridine

C10H14N2O6 (258.0852)


   

3-nitro-N-(1H-pyrrol-2-ylmethylene)benzohydrazide

3-nitro-N-(1H-pyrrol-2-ylmethylene)benzohydrazide

C12H10N4O3 (258.0753)


   

(7S)-4,7-Dihydroxy-10-oxo-3,5,9-trioxa-4-phosphaundecan-1-aminium 4-oxide

(7S)-4,7-Dihydroxy-10-oxo-3,5,9-trioxa-4-phosphaundecan-1-aminium 4-oxide

C7H17NO7P+ (258.0743)


   

D-1-(4-Chlorophenyl)-2-(acetamido)ethane boronic acid

D-1-(4-Chlorophenyl)-2-(acetamido)ethane boronic acid

C10H14BClNO4- (258.0704)


   

L-1-(4-Chlorophenyl)-2-(acetamido)ethane boronic acid

L-1-(4-Chlorophenyl)-2-(acetamido)ethane boronic acid

C10H14BClNO4- (258.0704)


   

1-[3-Hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]pyrimidine-2,4-dione

1-[3-Hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]pyrimidine-2,4-dione

C10H14N2O6 (258.0852)


   

Benzyl 2-phenylethenyl sulfone

Benzyl 2-phenylethenyl sulfone

C15H14O2S (258.0714)


   

N-1-Naphthalenyl-1,2-ethanediamine dihydrochloride

N-1-Naphthalenyl-1,2-ethanediamine dihydrochloride

C12H16Cl2N2 (258.069)


   

2-O-methylpseudouridine

2-O-methylpseudouridine

C10H14N2O6 (258.0852)


   

Cysteinyl-Histidine

Cysteinyl-Histidine

C9H14N4O3S (258.0787)


   

ribosylimidazoleacetic acid

ribosylimidazoleacetic acid

C10H14N2O6 (258.0852)


   

2-[(2-Furanylmethylthio)methyl]-5-methylimidazo[1,2-a]pyridine

2-[(2-Furanylmethylthio)methyl]-5-methylimidazo[1,2-a]pyridine

C14H14N2OS (258.0827)


   

N-(2-Pyridinyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

N-(2-Pyridinyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

C14H14N2OS (258.0827)


   

(3-Methylthio)benzyl benzoate

(3-Methylthio)benzyl benzoate

C15H14O2S (258.0714)


   

(4-Methylthio)benzyl benzoate

(4-Methylthio)benzyl benzoate

C15H14O2S (258.0714)


   

(1-Ribosylimidazole)-4-acetate

(1-Ribosylimidazole)-4-acetate

C10H14N2O6 (258.0852)


   

Histidylcysteine

Histidylcysteine

C9H14N4O3S (258.0787)


   

Histidinyl-Cysteine

Histidinyl-Cysteine

C9H14N4O3S (258.0787)


   
   
   

SCD1/5-IN-1

SCD1/5-IN-1

C12H10N4O3 (258.0753)


SCD1/5-IN-1 (Compound 10) is a SCD1/5 inhibitor. SCD1/5-IN-1 can be used for research of neurological disease[1].

   

methyl 5,6,7-trihydroxy-7-methyl-1-oxo-4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl 5,6,7-trihydroxy-7-methyl-1-oxo-4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate

C11H14O7 (258.0739)


   

8,15-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁹.0¹⁴,¹⁸]nonadeca-1(18),2(7),3,5,9,11(19),12,14,16-nonaen-13-ol

8,15-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁹.0¹⁴,¹⁸]nonadeca-1(18),2(7),3,5,9,11(19),12,14,16-nonaen-13-ol

C17H10N2O (258.0793)


   

(2r,3r,4s,5s,6r)-2-(furan-2-carbonyl)-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-(furan-2-carbonyl)-6-(hydroxymethyl)oxane-3,4,5-triol

C11H14O7 (258.0739)


   

5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1-methylpyrimidin-2-one

5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1-methylpyrimidin-2-one

C10H14N2O6 (258.0852)


   

5-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1-methylpyrimidin-2-one

5-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1-methylpyrimidin-2-one

C10H14N2O6 (258.0852)


   

methyl (4as,5r,6s,7r,7as)-5,6,7-trihydroxy-7-methyl-1-oxo-4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (4as,5r,6s,7r,7as)-5,6,7-trihydroxy-7-methyl-1-oxo-4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate

C11H14O7 (258.0739)


   

1-[(2r,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-5-methylpyrimidin-2-one

1-[(2r,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-5-methylpyrimidin-2-one

C10H14N2O6 (258.0852)


   

5-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1-methylpyrimidin-2-one

5-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1-methylpyrimidin-2-one

C10H14N2O6 (258.0852)


   

1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-5-methylpyrimidin-2-one

1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-5-methylpyrimidin-2-one

C10H14N2O6 (258.0852)